You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Bile Duct Neoplasms

Showing 1 - 25 of 4,183
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Common Bile Duct Diseases, Common Bile Duct Calculi, Common Bile Duct Stricture Trial (Dexamethasone 4mg)

Not yet recruiting
  • Common Bile Duct Diseases
  • +4 more
  • Dexamethasone 4mg
  • (no location specified)
Jul 12, 2023

A Single-center, Prospective Cohort Study on Differentiation of

Recruiting
  • Bile Duct Neoplasms
  • +2 more
  • cfDNA methylation detection
  • Xi'an, Shaanxi, China
    The First Affiliated Hospital of the Air Force Medical Universit
Oct 30, 2023

Bile Duct Cancer Trial (envolizumab , sovalteinib)

Not yet recruiting
  • Bile Duct Cancer
  • envolizumab , sovalteinib
  • (no location specified)
Jun 20, 2023

Hilar Cholangiocarcinoma, Intrahepatic Cholangiocarcinoma, Common Bile Duct Tumors Trial in Rotterdam (Endoscopic Ultrasound

Recruiting
  • Hilar Cholangiocarcinoma
  • +4 more
  • Endoscopic Ultrasound registration
  • Rotterdam, Zuid-Holland, Netherlands
    Erasmus University Medical Center
Jan 11, 2023

Looking At Bile Duct Cancer Patient Experience Patterns in

Not yet recruiting
  • Bile Duct Cancer
    • (no location specified)
    Jan 20, 2023

    Single-operator Cholangioscopy for Neoplastic Bile Duct Lesions

    Recruiting
    • Cholangiocarcinoma
    • Bile Duct Neoplasms
    • Single-operator cholangioscopy
    • Bucheon, Gyeonggi-do, Korea, Republic of
      Soonchunhyang University Bucheon Hospital
    Oct 26, 2022

    Metastatic Colorectal Cancer (Mcrc), Intrahepatic Cholangiocarcinoma (Icc), Colorectal Cancer Trial run by the National Cancer

    Recruiting
    • Metastatic Colorectal Cancer (Mcrc)
    • +7 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 23, 2023

    Inoperable Disease, Bile Duct Cancer Trial in Cluj-Napoca (Endoscopic ultrasound with fine needle biopsy)

    Recruiting
    • Inoperable Disease
    • Bile Duct Cancer
    • Endoscopic ultrasound with fine needle biopsy
    • Cluj-Napoca, Cluj, Romania
      IRGH "O. Fodor"
    Jun 14, 2022

    Tumors, Non-Neoplastic, Bile Duct Tumors Trial in Guayaquil (DSOC with AI biopsy guidance, DSOC biopsy without AI guidance)

    Active, not recruiting
    • Neoplasms
    • +3 more
    • DSOC with AI biopsy guidance
    • DSOC biopsy without AI guidance
    • Guayaquil, Guayas, Ecuador
      Carlos Robles-Medranda
    Aug 8, 2022

    Biliary Tract Diseases, Gallbladder Cancer, Extrahepatic Bile Duct Cancer Trial (no interventions)

    Not yet recruiting
    • Biliary Tract Diseases
    • +5 more
    • no interventions
    • (no location specified)
    Jun 1, 2023

    Ampullary Cancer, Bile Duct Cancer, Pancreas Cancer Trial in Zhanjiang (Modified Blumgart Anastomosis in LPD, conventional

    Enrolling by invitation
    • Ampullary Cancer
    • +3 more
    • Modified Blumgart Anastomosis in LPD
    • conventional Blumgart anastomosis in LPD
    • Zhanjiang, Guangdong, China
      The Affiliated Hospital of Guangdong Medical University
    Oct 7, 2023

    Biliary Cancer, Bile Duct Cancer, Cancer of the Bile Duct Trial run by the National Cancer Institute (NCI) (oxaliplatin,

    Not yet recruiting
    • Biliary Cancer
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    May 13, 2023

    Bile Duct Cancer, Cholangiocarcinoma, Cholangiocarcinoma Non-resectable Trial in Boston (Gemcitabine, Cisplatin, Durvalumab)

    Not yet recruiting
    • Bile Duct Cancer
    • +4 more
    • Boston, Massachusetts
      Beth Israel Deaconess Medical Center
    Jan 23, 2023

    RADIO FREQUENCY ABLATION IN UNRESECTABLE MALIGNANT BILIARY

    Recruiting
    • Bile Duct Neoplasms
    • Gall Bladder Carcinoma
    • Radio frequency ablation
    • Hyderabad, Telangana, India
      Asian Institute of Gastroenterology
    Apr 1, 2022

    Biliary Tract Carcinoma, Cholangiocarcinoma, Bile Duct Cancer Trial in Madison (Gemcitabine, Cisplatin, Zimberelimab)

    Not yet recruiting
    • Biliary Tract Carcinoma
    • +2 more
    • Madison, Wisconsin
      University of Wisconsin
    Sep 15, 2023

    Common Bile Duct Tumors, Non-Neoplastic Bile Duct Disorder Trial in Worldwide (AI model classification, DSOC endoscopist

    Active, not recruiting
    • Common Bile Duct Neoplasms
    • Non-Neoplastic Bile Duct Disorder
    • AI model classification
    • DSOC endoscopist experts' classification
    • New Brunswick, New Jersey
    • +5 more
    Mar 30, 2022

    ful Mutations in Solid Tumor Characterized by Next Generation

    Recruiting
    • Solid Tumor
    • +13 more
      • Aviano, Pordonone, Italy
        IRCCS, Centro di Riferimento Oncologico (CRO) di Aviano
      Sep 8, 2023

      Colorectal Cancer, Esophagus Cancer, Gastric Cancer Trial in Hangzhou (CEA-targeted CAR-T cells)

      Recruiting
      • Colorectal Cancer
      • +6 more
      • CEA-targeted CAR-T cells
      • Hangzhou, Zhejiang, China
      • +1 more
      Sep 18, 2023

      Cholangiocarcinoma, Bile Duct Cancer Trial in Toronto (Trifluridine/Tipiracil)

      Terminated
      • Cholangiocarcinoma
      • Bile Duct Cancer
      • Toronto, Ontario, Canada
        Sunnybrook Health Sciences Centre
      Nov 28, 2022

      Advanced Bile Duct Carcinoma, Advanced Gallbladder Carcinoma, Refractory Bile Duct Carcinoma Trial in Rochester (Irinotecan,

      Active, not recruiting
      Has Results
      • Advanced Bile Duct Carcinoma
      • +17 more
      • Rochester, Minnesota
        Mayo Clinic
      Jan 5, 2023

      Cholangiocarcinoma, Bile Duct Tumor, Biliary Tract Malignancy Trial run by the National Cancer Institute (NCI) (Tivozanib)

      Recruiting
      • Cholangiocarcinoma
      • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Aug 6, 2022

      Cholangiocarcinoma, Tumor, Klatskin Tumor Trial in Shatin (Temoporfin)

      Recruiting
      • Cholangiocarcinoma
      • +2 more
      • Shatin, N.t., Hong Kong
        Endoscopy Centre, Prince of Wales Hospital
      Mar 9, 2022

      Multi-Platform Profiling of Resected Biliary Tract Cancer

      Recruiting
      • Biliary Tract Cancer
      • +7 more
      • Multi-Platform Profiling with Organoid Drug Sensitivity Screening and ctDNA Monitoring
      • Chicago, Illinois
      • +1 more
      Jan 23, 2023

      Peritoneal Carcinomatosis, Peritoneal Metastases, Colorectal Cancer Trial in Ghent (PIPAC with Nal-IRI)

      Recruiting
      • Peritoneal Carcinomatosis
      • +7 more
      • PIPAC with Nal-IRI
      • Ghent, East-Flanders, Belgium
        UZ Ghent
      Dec 28, 2022

      Liver and Biliary Cancer Patients Treated With PD-1 Combination

      Active, not recruiting
      • Hepatocellular Carcinoma
      • Bile Duct Cancer
      • [68Ga]FAPI PET/CT and [18F]FDG PET/CT
      • Beijing, China
        Department of Nuclear Medicine, Peking Union Medical College Hop
      Dec 14, 2022